Insufficient measles antibody protection in 6‐month‐old Malawian infants: Reconsider vaccination schedule?

Abstract

Measles vaccination is currently recommended at 9 months, since maternal antibodies are supposed to protect infants until that age. In this study of 6‐month‐old Malawian infants 98.3% (58/59) had non‐protective IgG levels against measles, irrespective of HIV exposure. Anticipating the first dose at 6 months could be considered.